BRCA1 and central nervous system cancer: The credible region of a non-canonical 17q21.31 deletion included BRCA1. BRCA1 mutations are well-known in cancer56, with BRCA1 as a possible mediator of glioma cell proliferation, migration, and glioma stem cell self-renewal57.